HCS Pharma is a biotechnology start-up company offering services in pre-clinical in vitro research. 

 

Expertise: the development of new in vitro assays in pharmacology and toxicology in 2D and in 3D culture with BIOMIMESYS technology and their use in medium / high throughput screening by cell imaging: "High Content Analysis" (HCA) / "High Content Screening" (HCS). 

 

Its proprietary 3D culture technology, BIOMIMESYS® : unique and natural scaffold based on hyaluronic acid, biofunctionalized with other extracellular matrix components, to better mimic the cellular microenvironment of every organ

 

Its areas of expertise: neurodegenerative diseases (Parkinson, Alzheimer, ...), metabolic disease (steatosis, NAFLD, NASH, …) (immuno)oncology, toxicology (genotoxicity, hepatotoxicity, neurotoxicity ...).